Objective: Interleukin-6 (IL-6)-mediated inflammatory processes have been proposed to be involved in the pathogenesis of pregnancy-associated complications such as late unexplained intrauterine fetal death (IUFD). Therefore we determined whether a common guanine/cytosine polymorphism at position-174 of the promoter of the IL-6 gene (1L6) known to affect in vivo protein activity can serve as candidate genefor this condition.
Methods: In a multicenter case-control study, we evaluated the IL6 promoter polymorphism by pyrosequencing in 92 women with IUFD. Ninety-four healthy women with at least one uncomplicated full-term pregnancy and no history of IUFD served as the control group.
Results: No significant association was found between the presence of at least one mutant allele of the IL6 promoter polymorphism (P = .2; odds ratio = 1.5 [95% confidence interval, 0.8-2.7]) and the incidence of IUFD. In women with IUFD, the presence of at least one mutant allele of the IL6 promoter polymorphism did not influence timing offetal death (33.9 [5. 1]gestational weeks vs 34. 1 [4.9]gestational weeks, P = .8) or birth weight (2055 [1119] g vs 1963 [992] g, P = .7).
Conclusion: To our knowledge, we are thefirst to report on a common polymorphism of the IL6 promoter gene in women with late IUFD. The investigated IL6 promoter polymorphism can not be seen as candidate gene for IUFD in Caucasian women.
1. Hefler L, Jirecek S, Heim K, et al. Genetic polymorphisms associated with thrombophilia and vascular disease in women with unexplained late intrauterine fetal death: A multicenter study. J Soc Gynecol Investig2004;11:42-44.
2.
2. Martinelli I, Taioli E, Cetin I, et al. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med2000;343:1015-1018.
3.
3. Goldenberg RL, Thompson C. The infectious origins of still-birth. Am J Obstet Gynecol2003;189:861-873.
4.
4. Bashiri A, Horowitz S, Huleihel M, Hackmon R, Dukler D, Mazor M. Elevated concentrations of interleukin-6 in intra-amniotic infection with ureaplasma urealyticum in asymptomatic women during genetic amniocentesis. Acta Obstet Gynecol Scand1999;78:379-382.
5.
5. Blackwell S, Romero R, Chaiworapongsa T, et al. Maternal and fetal inflammatory responses in unexplained fetal death. J Matern Fetal Neonatal Med2003;14:151-157.
6.
6. Tolockiene E, Morsing E, Holst E, et al. Intrauterine infection may be a major cause of stillbirth in Sweden. Acta Obstet Gynecol Scand2001;80:511-518.
7.
7. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med1998;128:127-137.
8.
8. Diehl S, Rincon M. The two faces of IL-6 on Thl/Th2 differentiation. Mol Immunol2002;39:531-536.
9.
9. Asschert JG, Vellenga E, Ruiters MH, De Vries EG. Regulation of spontaneous and TNF/IFN-induced IL-6 expression in two human ovarian-carcinoma cell lines. Int J Cancer1999;82:244-249.
10.
10. Hefler LA, Grimm C, Ackermann S, et al. An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer. Cancer Res2003;63:3066-3068.
11.
11. Bowcock AM, Kidd JR, Lathrop GM, et al. The human “inter-feron-beta 2/hepatocyte stimulating factor/interleukin-6” gene: DNA polymorphism studies and localization to chromosome 7p2l. Genomics1988;3:8-16.
12.
12. Vickers MA, Green FR, Terry C, et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res2002;53:1029-1034.
13.
13. Jones SA, Horiuchi S, Topley N, et al. The soluble interleukin 6 receptor: Mechanisms of production and implications in disease. FASEB J2001; 15:43-58.
14.
14. Hulkkonen J, Vilpo J, Vilpo L, Koski T, Hurme M. Interleu-kin-1 beta, interleukin-1 receptor antagonist and interleukin-6 plasma levels and cytokine gene polymorphisms in chronic lymphocytic leukemia: Correlation with prognostic parameters. Haematologica2000;85:600-606.
15.
15. Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ. The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J2001;22:2243-2252.
16.
16. Wieser F, Fabjani G, Tempfer C, et al. Analysis of an interleu-kin-6 gene promoter polymorphism in women with endometriosis by pyrosequencing. J Soc Gynecol Investig2003;10:32-36.
17.
17. DeMichele A, Martin AM, Mick R, et al. Interleukin-6-174G- > C polymorphism is associated with improved outcome in high-nrsk breast cancer. Cancer Res2003;63:8051-8056.
18.
18. Trevilatto PC, Scarel-Caminaga RM, de Brito RB Jr, de Souza AP, Line SR. Polymorphism at position-174 of IL-6 gene is associated with susceptibility to chronic periodontitis in a Caucasian Brazilian population. J Clin Periodontol2003;30:438-442.
19.
19. Holmes CL, Russell JA, Walley KR. Genetic polymorphisms in sepsis and septic shock: Role in prognosis and potential for therapy. Chest2003;124:1103-1115.
20.
20. Treszl A, Toth-Heyn P, Kocsis I, et al. Interleukin genetic variants and the risk of renal failure in infants with infection. Pediatr Nephrol2002;17:713-717.
21.
21. Simhan HN, Krohn MA, Roberts JM, Zeevi A, Caritis SN. Interleukin-6 promoter-174 polymorphism and spontaneous preterm birth. Am J Obstet Gynecol2003;189:915-918.
22.
22. Daher S, Shulzhenko N, Morgun A, et al. Associations between cytokine gene polymorphisms and recurrent pregnancy loss. J Reprod Immunol2003;58:69-77.
23.
23. Hassan MI, Aschner Y, Manning CH, Xu J, Aschner JL. Racial differences in selected cytokine allelic and genotypic frequencies among healthy, pregnant women in North Carolina. Cytokine2003;21:10-16.
24.
24. Many A, Elad R, Yaron Y, Eldor A, Lessing JB, Kupferminc MJ. Third-trimester unexplained intrauterine fetal death is associated with inherited thrombophilia. Obstet Gynecol2002;99:684-687.
25.
25. Alfirevic Z, Mousa HA, Martlew V, Briscoe L, Perez-Casal M, Toh CH. Postnatal screening for thrombophilia in women with severe pregnancy complications. Obstet Gynecol2001;97:753-759.
